fluoxetine and ly 368975

fluoxetine has been researched along with ly 368975 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's6 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuller, RW; Gehlert, DR; Hemrick-Luecke, SK; Howbert, JJ; Krushinski, J; Robertson, DW; Schober, DA; Wong, DT1
Benvenga, MJ; Dreshfield, L; Fuller, RW; Gehlert, DR; Gleason, S; Hemrick-Luecke, SK; Tinsley, F; Wong, DT1
Marshall, M; Roth, JD; Rowland, NE1
Marshall, M; Robertson, K; Rowland, NE1
Lo, J; Robertson, K; Rowland, NE1
Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY1
Eastwood, BJ; Jones, CK; Need, AB; Shannon, HE1
Bachi, A; Cattaneo, A; Fazio, F; Filannino, MA; Kienle, MG; Magni, F; Masiello, V; Matarrese, M; Moresco, RM; Todde, S; Turolla, EA; Verza, E1

Other Studies

8 other study(ies) available for fluoxetine and ly 368975

ArticleYear
(R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake.
    Life sciences, 1995, Volume: 56, Issue:22

    Topics: Animals; Carrier Proteins; Cerebral Cortex; Fluoxetine; Hypothalamus; Isomerism; Male; Metaraminol; Myocardium; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Peripheral Nervous System; Rats; Rats, Sprague-Dawley; Serotonin; Symporters; Synaptosomes; Urethra

1995
The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Carrier Proteins; Eating; Fluoxetine; Male; Mice; Mice, Inbred ICR; Motor Activity; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Oxidopamine; Paroxetine; Propylamines; Rats; Rats, Sprague-Dawley; Symporters

1998
Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats.
    Psychopharmacology, 2000, Volume: 149, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Desipramine; Dexfenfluramine; Dose-Response Relationship, Drug; Drug Synergism; Eating; Female; Fluoxetine; Norepinephrine; Phentermine; Piperazines; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Receptor Agonists; Time Factors

2000
Anorectic effect of dehydroepiandrosterone combined with dexfenfluramine or thionisoxetine.
    European journal of pharmacology, 2001, May-04, Volume: 419, Issue:1

    Topics: Animals; Appetite; Appetite Depressants; Dehydroepiandrosterone; Dexfenfluramine; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Synergism; Eating; Female; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists

2001
Acute anorectic effect of single and combined drugs in mice using a non-deprivation protocol.
    Psychopharmacology, 2001, Volume: 157, Issue:2

    Topics: Animals; Appetite Depressants; Dexfenfluramine; Drug Combinations; Eating; Female; Fluoxetine; Food Deprivation; Mice; Mice, Inbred C57BL; Phentermine; Serotonin Receptor Agonists

2001
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:2

    Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride

2004
Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Neuropharmacology, 2006, Volume: 51, Issue:7-8

    Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Chemistry; Carrageenan; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Duloxetine Hydrochloride; Edema; Fluoxetine; Hot Temperature; Hyperalgesia; Male; Norepinephrine; Paroxetine; Pressure; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Venlafaxine Hydrochloride

2006
Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2007, Volume: 65, Issue:11

    Topics: Carbon Radioisotopes; Chromatography, High Pressure Liquid; Fluoxetine; Humans; Isotope Labeling; Ligands; Neurotransmitter Uptake Inhibitors; Norepinephrine; Positron-Emission Tomography; Radiopharmaceuticals

2007